Dr. Sulaiman Al Habib Medical Group Profits Rise 13% to SAR 2.3 Billion in 2024

Dr. Sulaiman Al Habib Medical Group announced an increase in net profit to SAR 2.3 billion by the end of 2024, reflecting a 13% growth compared to SAR 2.04 billion in 2023. The announcement follows the disclosure of the group’s preliminary financial results for the period ending December 31, 2024.

The company reported an operating profit of SAR 2.35 billion, up 12% from SAR 2.09 billion in the previous year.

Total equity (excluding non-controlling interests) rose 11% to SAR 7.17 billion, compared to SAR 6.48 billion in 2023. Meanwhile, earnings per share increased to SAR 6.62, up from SAR 5.85 in the prior year.

According to a statement on “Tadawul,” revenue grew by 17.79% in 2024, reaching SAR 11.2 billion—an increase of SAR 1.69 billion compared to SAR 9.51 billion in 2023. The company attributed this growth to a continued rise in revenue across all its sectors during the year.